Prior Auth Required

81317 - PMS2 (postmeiotic segregation increased 2 [S. cerevisiae]) (eg, hereditary non

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / ServicePMS2 (postmeiotic segregation increased 2 [S. cerevisiae]) (eg, hereditary non
Procedure / Service Description

Genetic and Molecular Testing Medical Necessity Guideline - promyelocytic leukemia) translocation analysis; single breakpoint (eg, intron 3, intron 6 or exon 6), qualitative or quantitative 81317 PMS2 (postmeiotic segregation increased 2 [S. cerevisiae]) (eg, hereditary non- polyposis colorectal cancer, Lynch syndrome) gene analysis; full sequence analysis Genetic and Molecular Testing Medical Necessity Guideline

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.